Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 225,755 | 210,322 | 262,759 | 234,178 | 249,328 |
| Cost of Goods | 26,994 | 21,031 | 23,592 | 20,410 | 25,642 |
| Gross Profit | 198,761 | 189,291 | 239,167 | 213,768 | 223,686 |
| Operating Expenses | 128,227 | 121,197 | 118,713 | 112,885 | 112,172 |
| Operating Income | 71,528 | 68,125 | 121,046 | 101,293 | 112,156 |
| Interest Expense | 139 | 26 | 5 | 26 | -705 |
| Other Income | 1,562 | 2,222 | 1,474 | 1,937 | 3,771 |
| Pre-tax Income | 72,951 | 70,321 | 122,515 | 103,204 | 116,632 |
| Income Tax | 20,906 | 18,915 | 34,198 | 29,838 | 37,344 |
| Net Income Continuous | 52,045 | 51,406 | 88,317 | 73,366 | 79,288 |
| Minority Interests | 551 | -123 | 197 | 207 | 217 |
| Net Income | $51,494 | $51,529 | $88,120 | $73,159 | $79,071 |
| EPS Basic Total Ops | 0.51 | 0.48 | 0.81 | 0.67 | 0.73 |
| EPS Basic Continuous Ops | 0.51 | 0.48 | 0.81 | 0.67 | 0.72 |
| EPS Diluted Total Ops | 0.50 | 0.48 | 0.81 | 0.67 | 0.72 |
| EPS Diluted Continuous Ops | 0.51 | 0.48 | 0.81 | 0.67 | 0.72 |
| EBITDA(a) | $88,075 | $83,185 | $135,606 | $116,142 | $126,888 |